BDBM646495 US20240024403, Compound Sanggenon

SMILES [#6]\[#6](-[#6])=[#6]/[#6]C12[#8]-c3c(-[#6]-4-[#6]=[#6](-[#6])-[#6]-[#6](-[#6]-4-[#6](=O)-c4ccc(-[#8])cc4-[#8])-c4ccc(-[#8])cc4-[#8])c(-[#8])cc(-[#8])c3-[#6](=O)C1([#8])[#8]-c1cc(-[#8])ccc21

InChI Key InChIKey=VUMCPXPDRABAGL-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 646495   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Unigen

US Patent
LigandPNGBDBM646495(US20240024403, Compound Sanggenon)
Affinity DataIC50:  2.40E+4nMAssay Description:The organic extract (8 g) from the stem barks of Milicia excelsa, obtained using the methods described in Example 1, was divided and loaded separatel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCB1 cannabinoid receptor-interacting protein 1(Homo sapiens (Human))
Unigen

US Patent
LigandPNGBDBM646495(US20240024403, Compound Sanggenon)
Affinity DataIC50:  3.50E+3nMAssay Description:The organic extract (8 g) from the stem barks of Milicia excelsa, obtained using the methods described in Example 1, was divided and loaded separatel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent